Patents Assigned to Nutramax Laboratories, Inc.
  • Patent number: 12194011
    Abstract: An anxiolytic composition formulated for oral administration to a mammal includes a synergistic combination of L-theanine, at least one of magnolia and an extract of magnolia, and at least one of phellodendron and an extract of phellodendron. The composition may include a combination of an extract of Magnolia officinalis and a extract of Phellodendron amurense. The synergistic combination may provide an anxiolytic change in a release pattern of one or more brain neurotransmitters, such as glutamate and/or ?-aminobutyric acid (GABA).
    Type: Grant
    Filed: December 28, 2022
    Date of Patent: January 14, 2025
    Assignee: Nutramax Laboratories, Inc.
    Inventors: Todd Henderson, David Griffin, David Bledsoe
  • Patent number: 11654186
    Abstract: The present disclosure relates to the synergistic combination of a sulforaphane precursor, an enzyme capable of converting the sulforaphane precursor to sulforaphane, a cofactor of the enzyme, and a glucan. The present disclosure also relates to the synergistic combination of sulforaphane or a derivative thereof and a glucan. The present disclosure also relates to the synergistic combination of a broccoli extract or powder and a glucan. The glucan may be a ?-glucan. The glucan may be provided in a mushroom extract or powder selected from one or more of a maitake, a shiitake, or a reishi mushroom. Compositions and methods relating to these combinations are described.
    Type: Grant
    Filed: December 3, 2019
    Date of Patent: May 23, 2023
    Assignee: Nutramax Laboratories, Inc.
    Inventors: Brian Cornblatt, Grace Cornblatt, Anton Bzhelyansky, Robert Henderson
  • Patent number: 11241444
    Abstract: Compositions are described including a combination of hydroxytyrosol and 3-O-acetyl-11-keto-?-boswellic acid. The hydroxytyrosol may be sourced from an olive extract and the 3-O-acetyl-11-keto-?-boswellic acid may be sourced from a Boswellia serrata extract. The compositions may be formulated for oral administration to a mammalian or an avian subject. Methods for preventing or reducing an inflammatory response in connective tissue are provided, the methods comprising orally administering the compositions to a subject in need thereof.
    Type: Grant
    Filed: March 26, 2020
    Date of Patent: February 8, 2022
    Assignee: Nutramax Laboratories, Inc.
    Inventors: Todd Henderson, David Griffin
  • Patent number: 11224639
    Abstract: The invention relates to the combination of a sulforaphane precursor, an enzyme capable of converting the sulforaphane precursor to sulforaphane, an enzyme potentiator, and a milk thistle extract or powder. The invention also relates to the combination of a sulforaphane or a derivative thereof and a milk thistle extract or powder. The invention also relates to the combination of a broccoli extract or powder and a milk thistle extract or powder. The invention provides compositions and methods relating to these combinations.
    Type: Grant
    Filed: May 4, 2020
    Date of Patent: January 18, 2022
    Assignee: Nutramax Laboratories, Inc.
    Inventors: Brian Cornblatt, Grace Cornblatt, Anton Bzhelyansky, Robert Henderson
  • Patent number: 8846118
    Abstract: The present invention relates to compositions for the protection, treatment and repair of connective tissues in humans and animals comprising any or all of anabolic, anti-catabolic, anti-oxidant and analgesic agents, including aminosugars, S-adenosylmethionine, arachadonic acid, GAGs, including pentosan, collagen type II, tetracyclines or tetracycline-like compounds, diacerin, super oxide dismutase, L-ergothionine, one or more avocado/soybean unsaponifiables, and an analgesic, e.g., acetaminophen, and to methods of treating humans and animals by administration of these novel compositions to humans and animals in need thereof.
    Type: Grant
    Filed: August 21, 2008
    Date of Patent: September 30, 2014
    Assignee: Nutramax Laboratories, Inc.
    Inventors: Todd R. Henderson, Tarek Hammad, Medhat Soliman, Barbara E. Corson, Louis Lippiello, Robert W. Henderson
  • Patent number: 8808770
    Abstract: The present invention relates to a composition and a kit for the protection, treatment and repair of cartilage in humans and animal joints. The composition or kit contains a combination of unsaponifiable lipids together with one or more of polyphenols and/or catechins. Preferably, the composition or kit contains avocado:soybean unsaponifiables (ASU) and green tea.
    Type: Grant
    Filed: May 14, 2010
    Date of Patent: August 19, 2014
    Assignee: Nutramax Laboratories, Inc.
    Inventors: Todd R. Henderson, Louis Lippiello, Charles Filburn, David Griffin
  • Patent number: 8753697
    Abstract: The present invention relates to compositions for the protection, treatment and repair of connective tissues in humans and animals comprising any or all of anabolic, anti-catabolic, anti-oxidant and analgesic agents, including aminosugars, S-adenosylmethionine, arachadonic acid, GAGs, including pentosan, collagen type II, tetracyclines or tetracycline-like compounds, diacerin, super oxide dismutase, L-ergothionine, one or more avocado/soybean unsaponifiables, and an analgesic, e.g., acetaminophen, and to methods of treating humans and animals by administration of these novel compositions to humans and animals in need thereof.
    Type: Grant
    Filed: September 24, 2009
    Date of Patent: June 17, 2014
    Assignee: Nutramax Laboratories, Inc.
    Inventors: Todd R. Henderson, Tarek Hammad, Medhat Soliman, Barbara Corson, Louis Lippiello, Robert Henderson
  • Patent number: 8568803
    Abstract: The present invention relates to compositions for the modulation of inflammation in connective tissues in humans and animals and the modulation of markers of such inflammation, including COX-2, TNF-a, IL-1 (3, iNOS, p38, and chemokines, comprising any or all of anabolic, anti-catabolic, anti-oxidant and analgesic agents, including aminosugars, S-adenosylmethionine, arachadonic acid, GAGs, including pentosan, collagen type II, tetracyclines or tetracycline-like compounds, diacerin, super oxide dismutase, L-ergothioneine, methyl sulfanylmethane, one or more avocado/soybean unsaponifiables, and an analgesic, e.g., acetaminophen, and to methods of treating humans and animals by administration of these novel compositions to humans and animals in need thereof.
    Type: Grant
    Filed: August 7, 2009
    Date of Patent: October 29, 2013
    Assignee: Nutramax Laboratories, Inc.
    Inventors: Todd R. Henderson, Carmelita Frondoza
  • Publication number: 20120294960
    Abstract: Methods comprising administration of: (i) avocado/soybean unsaponifiables and (ii) lipoic acid or derivatives thereof, to a mammalian or an avian subject are provided. This invention also relates to orally administrable compositions comprising avocado/soybean unsaponifiables and lipoic acid or derivatives thereof.
    Type: Application
    Filed: May 20, 2011
    Publication date: November 22, 2012
    Applicant: Nutramax Laboratories, Inc.
    Inventors: Carmelita Frondoza, Todd R. Henderson, Reinhard Grzanna
  • Publication number: 20080176935
    Abstract: The present invention relates to a composition and a kit for the protection, treatment and repair of cartilage in humans and animal joints. The composition or kit contains a combination of unsaponifiable lipids together with one or more of polyphenols and/or catechins.
    Type: Application
    Filed: August 8, 2007
    Publication date: July 24, 2008
    Applicant: Nutramax Laboratories, Inc.
    Inventors: Todd R. Henderson, Louis Lippiello, Charles Filburn, David Griffin
  • Patent number: 6863906
    Abstract: This invention provides therapeutic compositions and combinations for the protection, treatment and repair of liver tissue. The invention relates to novel compositions and combinations comprising two or more compounds selected from the group consisting of S-adenosylmethionine, L-ergothioneine, and a substance selected from the group consisting of constituents of Milk thistle (Silybum marianum), silymarin and active components of silymarin, whether naturally, synthetically, or semi-synthetically derived, and to methods of preventing and treating liver disease and of repairing damaged liver tissue. The invention also provides a method of administering these compositions and combinations to humans or animals in need thereof.
    Type: Grant
    Filed: May 24, 2002
    Date of Patent: March 8, 2005
    Assignee: Nutramax Laboratories, Inc.
    Inventors: Todd R. Henderson, Barbara E. Corson
  • Patent number: 6797289
    Abstract: The present invention relates to compositions for the protection, treatment and repair of connective tissues in humans and animals comprising any or all of anabolic, anti-catabolic, anti-oxidant and analgesic agents, including aminosugars, S-adenosylmethionine, arachadonic acid, GAGs, including pentosan, collagen type II, tetracyclines or tetracycline-like compounds, diacerin, super oxide dismutase, L-ergothionine, one or more avocado/soybean unsaponifiables, and an analgesic, e.g., acetaminophen, and to methods of treating humans and animals by administration of these novel compositions to humans and animals in need thereof.
    Type: Grant
    Filed: July 11, 2002
    Date of Patent: September 28, 2004
    Assignee: Nutramax Laboratories, Inc.
    Inventors: Todd R. Henderson, Tarek Hammad, Medhat Soliman, Barbara Corson, Robert Henderson
  • Patent number: 6583123
    Abstract: A composition for the protection, treatment and repair and for reducing the inflammation of connective tissue in mammals and a method for the treatment of connective tissue in mammals by the administration of the composition. The composition includes S-Adenosylmethionine (SAM), and a component selected from an aminosugar or salts thereof (e.g., glucosamine) or glycosaminoglycans (e.g., chondroitin salts) or mixtures or fragments thereof. The composition optionally includes manganese which promotes the production of connective tissue matrix. The composition also optionally includes methyl donors or methyl donor cofactors, such as vitamin B12, vitamin B6, folic acid, dimethylglycine or trimethylglycine.
    Type: Grant
    Filed: April 16, 2001
    Date of Patent: June 24, 2003
    Assignee: Nutramax Laboratories, Inc.
    Inventors: Robert W. Henderson, Tarek Hammad
  • Patent number: 6555141
    Abstract: This invention provides therapeutic compositions for the protection, treatment and repair of liver tissue. The invention relates to novel compositions comprising two or more compounds selected from the group consisting of S-adenosylmethionine, L-ergothioneine, and a compound selected from the group consisting of Milk thistle (Silybum marianum), silymarin and active components of silymarin, whether naturally, synthetically, or semi-synthetically derived, and to methods of preventing and treating liver disease and of repairing damaged liver tissue. The invention also provides a method of administering these compositions to humans or animals in need thereof.
    Type: Grant
    Filed: February 24, 1999
    Date of Patent: April 29, 2003
    Assignee: Nutramax Laboratories, Inc.
    Inventors: Barbara E. Corson, Todd R. Henderson
  • Patent number: 6492349
    Abstract: A therapeutic composition for the protection, treatment and repair of connective tissue in mammals and a method for the treatment of connective tissue in mammals by the administration of the composition. The composition includes glucosamine and preferably chondroitin sulfate or fragments thereof. The composition optionally includes manganese ascorbate which catalyzes the production of collagen and proteoglycans from the glucosamine and chondroitin sulfate.
    Type: Grant
    Filed: December 23, 1996
    Date of Patent: December 10, 2002
    Assignee: Nutramax Laboratories, Inc.
    Inventor: Robert W. Henderson
  • Patent number: D926964
    Type: Grant
    Filed: April 7, 2020
    Date of Patent: August 3, 2021
    Assignee: Nutramax Laboratories, Inc.
    Inventors: Brian Adams, David Griffin, Hubert Ratkowski
  • Patent number: D941457
    Type: Grant
    Filed: April 7, 2020
    Date of Patent: January 18, 2022
    Assignee: Nutramax Laboratories, Inc.
    Inventors: Brian Adams, David Griffin, Hubert Ratkowski
  • Patent number: D941458
    Type: Grant
    Filed: August 11, 2020
    Date of Patent: January 18, 2022
    Assignee: Nutramax Laboratories, Inc.
    Inventors: Brian Adams, David Griffin, Hubert Ratkowski
  • Patent number: D941985
    Type: Grant
    Filed: April 7, 2020
    Date of Patent: January 25, 2022
    Assignee: Nutramax Laboratories, Inc.
    Inventors: Brian Adams, David Griffin, Hubert Ratkowski
  • Patent number: D942609
    Type: Grant
    Filed: August 11, 2020
    Date of Patent: February 1, 2022
    Assignee: Nutramax Laboratories, Inc.
    Inventors: Brian Adams, David Griffin, Hubert Ratkowski